Immediate Impact

1 from Science/Nature 53 standout
Sub-graph 1 of 24

Citing Papers

Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
2025 Standout
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
2025 Standout
2 intermediate papers

Works of Dinko Rekić being referenced

ETESIAN: A PHASE 2B STUDY OF THE EFFICACY, SAFETY AND TOLERABILITY OF AZD8233, A PCSK9-TARGETED ANTISENSE OLIGONUCLEOTIDE, IN PATIENTS WITH DYSLIPIDEMIA
2022
Acute Exacerbation and Decline in Forced Vital Capacity Are Associated with Increased Mortality in Idiopathic Pulmonary Fibrosis
2017

Author Peers

Author Last Decade Papers Cites
Dinko Rekić 46 64 57 140 76 29 433
Yoshiaki Ohtsu 10 21 97 180 85 26 462
Kosalaram Goteti 33 23 130 40 87 32 467
Jacqueline L. Olin 47 38 114 54 85 35 447
Yukio Suga 50 31 43 55 74 57 475
Atsunori Kaibara 51 158 70 63 58 21 500
Matthew Hoffmann 18 36 201 58 111 39 502
Pauline Bosco‐Lévy 27 69 54 58 59 32 377
Christine Reynolds 57 16 65 56 91 15 410
Lamia El Wakeel 70 15 98 62 76 36 445
S K Garg 41 15 32 92 71 30 478

All Works

Loading papers...

Rankless by CCL
2026